Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

TTC7A Gene Sequencing – Multiple Intestinal Atresia (NGS) in UAE | 2800 AED

Executive Summary & Core Metrics

99.9% Diagnostic Sensitivity – ISO 15189-accredited NGS sequencing with full gene coverage and copy number analysis.

Premium Home Collection – Cold-chain certified phlebotomy (8 AM–11 PM), VIP mobile service included.

Post-Test Clinical Guidance – Telephonic interpretation with a DHA-licensed clinical geneticist.

Insurance Support – Direct billing verification via WhatsApp at +971 54 548 8731.

Test Overview & Methodology

The TTC7A gene is critical for intestinal epithelial homeostasis and immune function. This NGS test analyzes the entire coding region and splice sites to detect pathogenic variants causing multiple intestinal atresia, often syndromic with combined immunodeficiency.

FeatureOur TTC7A NGS TestClosest Alternative
MethodNGS (Next-Generation Sequencing)Sanger sequencing (single exon screening)
CoverageFull gene ± 20 bp intronic flanks, CNV detectionSelected exons only
Turnaround3–4 Weeks4–6 Weeks (fragmented)
Sample TypesWhole blood, DNA, or dry blood spot (FTA card)Typically blood only

Physician Insight & Safety Protocols

“As a clinical geneticist, I emphasize that a positive TTC7A result is not a diagnosis in isolation. It must be correlated with intestinal biopsy findings, immune function panels, and the child’s clinical phenotype. Parents, your pediatrician and geneticist will guide you through the meaning of any variant, especially with respect to reproductive options and potential hematopoietic stem cell transplantation.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License No. 9294403

Critical Medication Advisory

Do not discontinue prescribed medication or modify therapy without consulting your treating physician. This test does not replace clinical monitoring or immediate surgical intervention.

Exclusion Criteria & Emergency Red Flags

  • Patients requiring urgent surgical bowel resection are not eligible for home collection – proceed directly to hospital.
  • If you observe bilious vomiting, abdominal distension, or failure to pass meconium in a newborn, call emergency services immediately.
  • This test is not indicated for acute care; it is elective and requires genetic counseling before sampling.

Patient FAQ & Clinical Guidance

1. What exactly does the TTC7A gene test detect and how reliable is it?

This test identifies pathogenic or likely pathogenic variants across the entire TTC7A coding sequence with 99% analytical sensitivity and specificity, confirming the molecular cause of multiple intestinal atresia and associated immunodeficiency when clinical signs are present.

2. Does the test require fasting or special preparation?

No special preparation is required; a single blood sample or dried blood spot on an FTA card is sufficient. Prior genetic counseling to document family history is strongly recommended before sampling.

3. Can this test be used for prenatal diagnosis of multiple intestinal atresia?

Yes, with prior genetic counseling and parental variant confirmation, TTC7A NGS can be applied to amniocytes or chorionic villus sampling. Prenatal testing must follow UAE regulatory oversight for minors and requires explicit consent.

4. How long does the result take and will I receive medical explanation?

Results are available within 3 to 4 weeks, followed by a telephonic consultation with a clinical geneticist to interpret the report and discuss follow-up recommendations.

5. What if I need the sample collected at home?

Home collection is available through our VIP Mobile Phlebotomy service with temperature-controlled cold-chain, operating daily from 8 AM to 11 PM. Exclusions apply for acute surgical cases as noted in the safety protocol.

UAE Regulatory & Data Privacy Adherence

Data Protection & Legal Compliance

This testing service fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is encrypted, stored securely, and used solely for diagnostic purposes with your explicit consent.

ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139). DHA Facility License: 1143. Corporate Lab: DNA Labs UAE.

Clinical & Logistical Metadata

Test NameTTC7A Gene Sequencing (NGS) for Multiple Intestinal Atresia
Price (AED)2,800 AED
Turnaround Time21–28 days (3–4 weeks)
Sample Type / MatrixWhole blood (5 mL EDTA), extracted DNA, or dried blood spot (FTA card). VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM–11 PM.
Methodology UsedNext-Generation Sequencing (NGS) with full gene coverage, intronic flanks ±20 bp, and CNV detection.
ICD-10-CM CodeQ41.8
LOINC Code81255-6
DHA Facility License & AddressDHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE)

Compliant with UAE Federal Decree-Law No. 45 of 2021 (PDPL), Federal Law No. 2 of 2019, and Federal Decree-Law No. 4 of 2016. ISO 9001:2015 Cert: INT/EGQ/2509DA/3139. DHA Facility License: 1143. Corporate Lab: DNA Labs UAE.

Medical disclaimer: This page is for informational purposes only and is not a substitute for professional medical advice. Always consult a qualified physician.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians